# Oral Testosterone for Fatigue in Male Multiple Sclerosis Patients

> **NCT01516554** · PHASE2 · TERMINATED · sponsor: **Health Sciences Centre, Winnipeg, Manitoba** · enrollment: 3 (actual)

## Conditions studied

- Multiple Sclerosis
- Fatigue

## Interventions

- **DRUG:** Testosterone undecanoate
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01516554
- **Lead sponsor:** Health Sciences Centre, Winnipeg, Manitoba
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-02
- **Primary completion:** 2014-01
- **Final completion:** 2014-07
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** Poor recruitment
- **Last updated:** 2014-07-08

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01516554

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01516554, "Oral Testosterone for Fatigue in Male Multiple Sclerosis Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01516554. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*